Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Cassava, Ebix, and the WWE and Encourages Investors to Contact the Firm

New York, New York, UNITED STATES


NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: GDRX), Cassava Sciences, Inc. (NASDAQ: SAVA), Ebix, Inc. (NASDAQ: EBIX), and World Wrestling Entertainment, Inc. (NYSE: WWE). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

GoodRx Holdings, Inc. (NASDAQ: GDRX)

On May 9, 2022, after the market closed, GoodRx announced its first quarter 2022 financial results and withdrew its fiscal 2022 guidance. In its shareholder letter, the Company stated that “a grocery chain had taken actions that impacted acceptance of discounts from most PBMs for a subset of drugs.” The Company expects “the grocer issue . . . could have an estimated revenue impact of roughly $30 million [and] will be ongoing without amelioration through Q2.” As a result, GoodRx “believe[s] it is unlikely [it] will be able to achieve the FY 2022 guidance” previously provided.

On this news, GoodRx’s stock fell $2.78, or 25.9%, to close at $7.97 on May 10, 2022, thereby injuring investors.

For more information on the GoodRx investigation go to: https://bespc.com/cases/GDRX

Cassava Sciences, Inc. (NASDAQ: SAVA)

On April 18, 2022, The New York Times published an article entitled “Scientists Question Data Behind an Experimental Alzheimer’s Drug.”  The article addressed Cassava’s experimental Alzheimer’s drug, simufilam, and reported that one of Cassava’s advisers, Dr. H.Y. Wang, had five papers he authored retracted from the scientific journal PLoS One after an in-depth investigation revealed “serious concerns about the integrity and the reliability of the results.” 

On this news, Cassava’s stock price fell sharply during intraday trading on April 19, 2022.

For more information on the Cassava investigation go to: https://bespc.com/cases/SAVA

Ebix, Inc. (NASDAQ: EBIX)

On June 16, 2022, Hindenburg issued a short report on Ebix titled, “Ebix: This House of 'Cards' Seems To Have a Glaring Fake Revenue Problem”. Hindenburg stated that in February 2021, “Ebix auditor RSM resigned because the company refused to provide evidence regarding 'unusual transactions related to the Company’s gift card business in India.' The auditor was unable to obtain evidence to allow it to evaluate the business purposes behind the transactions. Hindenburg’s review of Indian corporate records shows that these 'unusual transactions' have increased since RSM’s departure.”

On this news, Ebix stock fell $8.81, or 37.6%, to close at $14.59 on June 16, 2022.

World Wrestling Entertainment, Inc. (NYSE: WWE)

WWE is the subject of a June 15, 2022, article in the Wall Street Journal titled: “WWE Board Probes Secret $3 Million Hush Pact by CEO Vince McMahon, Sources Say.” According to the article, the Company’s board “is investigating a secret $3 million settlement that longtime chief executive Vince McMahon agreed to pay to a departing employee with whom he allegedly had an affair, according to documents and people familiar with the board inquiry.” The article continues, “the board’s investigation, which began in April, has unearthed other, older nondisclosure agreements involving claims by former female WWE employees of misconduct by Mr. McMahon and one of his top executives, John Laurinaitis, the head of talent relations at WWE, the people said.”

On June 17, 2022, the Company issued a press release stating, “a Special Committee of the Board is conducting an investigation into alleged misconduct by its Chairman and CEO Vincent McMahon and John Laurinaitis, head of talent relations, and that, effective immediately, McMahon has voluntarily stepped back from his responsibilities as CEO and Chairman of the Board until the conclusion of the investigation.”

On this news, WWE stock fell $1.94, or 3%, to close at $62.51 on June 17, 2022.

For more information on the WWE investigation go to: https://bespc.com/cases/WWE

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com